Navigation Links
Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
Date:10/22/2008

218,247 $1,231,905 $3,717,378 $3,751,030

Basic Earnings per Share $0.91 $0.92 $2.79 $2.79

Average Number of Common

Shares Outstanding during

Each Period - Basic 1,332,744 1,343,036 1,333,542 1,343,897

Diluted Earnings per Share $0.90 $0.90 $2.75 $2.74

Average Number of Common

Shares Outstanding during

Each Period - Diluted 1,356,909 1,372,145 1,358,902 1,376,505

See Notes to Results of Operations.

Notes to Results of Operations

(1) The average number of common shares outstanding for diluted earnings per share is higher than for basic earnings per share due to the assumed conversion of the Company's outstanding convertible senior debentures, outstanding stock options, deferred contingent common stock awards, performance share awards, restricted stock awards and convertible preferred stock into common stock equivalents using the treasury stock method. For purposes of calculating diluted earnings per share, interest expense, net of capitalized interest and taxes related to the Company's outstanding convertible senior debentures is added back to reported net income, and the additional shares of common stock (assuming conversion) are included in total shares outstanding. Interest expense, net of capitalized interest and taxes related to these debentures was $5,687 and $19,523 for the 2008 third quarter and first nine months, respectively, compared with $7,838 and $23,617 for the 2007 third quarter and first nine months, respectively.

(2) Other (income) expense, net included royalty income for the 2008 third quarter and first nine months of $34,190 and $202,179, respectively, compared with $63,265 and $202,048 for the prior year. The 2008 first nine months included a one-time royalty milestone payment of $60,000 related to the previous
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
2. Wyeth Announces Increase in Common Stock Dividend
3. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
4. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
5. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
6. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
7. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
8. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
9. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
10. Wyeth Declares Common and Preferred Stock Dividends
11. Wyeth Pharmaceuticals Announces Organizational Change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , October 20, 2014 , ... (GI) disorders and the delivery of care has revealed ... and worrying inequalities in the provision of healthcare services ... was commissioned by United European Gastroenterology (UEG), have been ... and public awareness of the burden of GI disorders ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Partners LLC, announced today that Ellen Teplitzky, an ... support for the pharmaceutical industry, has joined the ... of its legal services practice. NDA Partners ... expert witness and testimony, to top law firms ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... Genome Research Institute (NHGRI) of the National Institutes of ... to date to chart the genetic changes involved in ... The findings should help pave the way for more ... cause of cancer deaths. , In a paper published ...
... team of scientists has performed the ultimate miniaturisation of ... atom. This breakthrough is a key step in bringing ... on the fundamental theory of quantum mechanics which could ... quantum world, objects such as atoms are allowed to ...
... PALO ALTO, Calif., Oct. 22 Telik, Inc.,(Nasdaq: ... call and,webcast will be held on Wednesday, November 5, ... following the release earlier that day of the,company,s financial ... The conference call will be accessible via Telik,s ...
Cached Biology Technology:Large-scale genetic study sheds new light on lung cancer 2Large-scale genetic study sheds new light on lung cancer 3Large-scale genetic study sheds new light on lung cancer 4Large-scale genetic study sheds new light on lung cancer 5Memoirs of a qubit: Hybrid memory solves key problem for quantum computing 2
(Date:10/17/2014)... from the University of Copenhagen have shown for the ... lungs of Cystic fibrosis patients, giving them the opportunity ... in chronic infections. , The study also discovered the ... (CF) patients was halted or slowed down by the ... all the oxygen and helped "suffocate" the bacteria, forcing ...
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... Washington land managers have a new synthesis of recent ... mixed-conifer (MMC) forests in the two states. , ... Eastern Oregon and Washington: A Synthesis of the Relevant ... general technical report published by the U.S. Forest Service,s ... a request from managers for a synthesis of the ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2
... Biofuels based on ethanol, vegetable oil and other renewable ... a way to reduce fossil fuel dependence and limit ... a biologist at the University of Washington, Bothell, shows ... might have exactly the opposite impacts than intended. The ...
... Clouds have typically posed a problem to scientists using ... where humans live and breathe, because they block the ... Earth,s surface. It turns out, however, that these "obstructions" ... characteristics actually serve a valuable role in Earth,s climate. ...
... RELEASE, 26 May 2008] Scientists at the Swedish medical ... that is much cheaper than those currently in use ... make it possible to map disease genes in large ... for new treatments for a wide variety of diseases. ...
Cached Biology News:Some biofuels might do more harm than good to the environment, study finds 2Some biofuels might do more harm than good to the environment, study finds 3Satellites illuminate pollution's influence on clouds 2Satellites illuminate pollution's influence on clouds 3New cheaper method for mapping disease genes 2
... The Bioactive peptides are molecules of peptidic ... behaviour or activity which can be developed ... chemical and agro-food applications. In this way ... with superior properties for therapeutic applications. Primm ...
... InnoScan700 is a fluorescence scanner with ... biochip (Staggered/Orange Packing, Protein, CGH, ) spotted ... the range of InnoScan700 scanners include three ... InnoScan700A is a simultaneous dual fluorescence scanner ...
... within neurons in vesicles called synaptosomes. ... synaptic bouton. Synaptosomes may be ... other cellular debris. Abnormalites in neurotransmitter ... pathological condtions. Conditions of release ...
... DNAscope is an integrated confocal laser scanner ... integrated into your specific application. GeneFocus can ... tailor the system to your specifications. ... design has been modularized and built onto ...
Biology Products: